Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2016

View Archived Issues

Argos Therapeutics and Personalis enter research agreement

BlueRock obtains sublicense to cardiac stem cell technologies from VistaGen

Mersana begins first-in-human study of XMT-1522 in breast cancer and HER2-expressing cancers

Nanobiotix's NBTXR-3 shows positive results in phase I/II study in liver cancer

Basaglar becomes available in the U.S.

IRL patents cortical cathecolaminergic neurotransmission modulators

Roche terminates agreement with Pacific Biosciences

Clinical cancer candidate CYC-140 shows antiproliferative activity

RespireRx Pharmaceuticals' CX-1739 safe, well-tolerated in phase IIa study

Kyorin Pharmaceutical discloses FPR2 agonists

Merck & Co. describes HIV integrase inhibitors

Redx Pharma develops antibacterial agents

Amgen describes BiTE antibody targeting EGFR, CD3

Aurigene Discovery Technologies presents CDK inhibitors

OrthoTrophix's TPX-100 improves knee function in phase II study in knee osteoarthritis

Phase I dose-escalation study results for DS-3032b

Target ALS Foundation gives Karyopharm grant supporting KPT-350 research

FDA clears IND for phase I trials of CER-209 for NASH and NAFLD

Poziotinib shows efficacy in a model harboring insertions in exon 20 of EGFR

Noxxon Pharma enters agreement to study NOX-A12 with pembrolizumab

EMA grants orphan designation to REGN-2477 for fibrodysplasia ossificans progressiva

Takara Bio and Otsuka sign exclusive license agreement for the oncolytic virus HF10 in Japan

Evotec and Celgene form drug discovery and development collaboration in neurodegenerative diseases

Novartis to acquire Ziarco

SKLB-518 shows promise to overcome drug-resistant mutations of Bcr-Abl1

CFDA grants approval for clinical trials of fadanafil

Agios discontinues development of AG-519

Medgenics changes name

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...